Miramar Capital LLC bought a new position in Klaviyo, Inc. (NYSE:KVYO - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 28,572 shares of the company's stock, valued at approximately $1,178,000.
Several other hedge funds and other institutional investors have also bought and sold shares of the company. Whale Rock Capital Management LLC lifted its stake in shares of Klaviyo by 608.9% in the 3rd quarter. Whale Rock Capital Management LLC now owns 3,600,606 shares of the company's stock valued at $127,389,000 after acquiring an additional 3,092,725 shares during the last quarter. Bank of New York Mellon Corp lifted its position in Klaviyo by 5.0% in the fourth quarter. Bank of New York Mellon Corp now owns 2,926,187 shares of the company's stock valued at $120,676,000 after purchasing an additional 140,127 shares during the last quarter. Geode Capital Management LLC boosted its stake in shares of Klaviyo by 45.1% during the third quarter. Geode Capital Management LLC now owns 786,186 shares of the company's stock valued at $27,827,000 after purchasing an additional 244,447 shares during the period. Mayflower Financial Advisors LLC grew its holdings in shares of Klaviyo by 181.4% in the third quarter. Mayflower Financial Advisors LLC now owns 684,948 shares of the company's stock worth $24,233,000 after purchasing an additional 441,500 shares during the last quarter. Finally, Two Sigma Advisers LP increased its stake in shares of Klaviyo by 121.5% in the third quarter. Two Sigma Advisers LP now owns 673,500 shares of the company's stock worth $23,828,000 after buying an additional 369,400 shares during the period. Hedge funds and other institutional investors own 45.43% of the company's stock.
Analyst Upgrades and Downgrades
A number of analysts have recently weighed in on the stock. Benchmark increased their target price on shares of Klaviyo from $40.00 to $51.00 and gave the stock a "buy" rating in a report on Wednesday, February 19th. Stifel Nicolaus upped their price objective on shares of Klaviyo from $45.00 to $54.00 and gave the stock a "buy" rating in a report on Thursday, February 20th. Barclays increased their price target on shares of Klaviyo from $47.00 to $51.00 and gave the stock an "overweight" rating in a research note on Thursday, February 20th. Needham & Company LLC increased their target price on Klaviyo from $46.00 to $56.00 and gave the stock a "buy" rating in a research report on Thursday, February 20th. Finally, Morgan Stanley upped their price target on Klaviyo from $47.00 to $50.00 and gave the stock an "equal weight" rating in a research note on Thursday, February 20th. Five equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $49.44.
View Our Latest Report on Klaviyo
Insider Buying and Selling
In related news, CFO Amanda Whalen sold 15,000 shares of the business's stock in a transaction on Friday, December 13th. The stock was sold at an average price of $39.39, for a total transaction of $590,850.00. Following the completion of the transaction, the chief financial officer now owns 391,820 shares in the company, valued at $15,433,789.80. The trade was a 3.69 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, President Stephen Eric Rowland sold 36,710 shares of the stock in a transaction on Friday, March 7th. The stock was sold at an average price of $35.08, for a total value of $1,287,786.80. Following the completion of the sale, the president now owns 246,254 shares in the company, valued at approximately $8,638,590.32. The trade was a 12.97 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 126,246 shares of company stock worth $5,007,708. 53.24% of the stock is owned by corporate insiders.
Klaviyo Trading Down 7.5 %
KVYO stock traded down $2.61 on Thursday, hitting $32.00. The company had a trading volume of 1,388,525 shares, compared to its average volume of 1,223,795. The stock has a market cap of $8.74 billion, a price-to-earnings ratio of -177.75 and a beta of 0.86. The stock's 50-day simple moving average is $42.43 and its 200 day simple moving average is $38.65. Klaviyo, Inc. has a 12-month low of $21.26 and a 12-month high of $49.55.
Klaviyo (NYSE:KVYO - Get Free Report) last posted its earnings results on Wednesday, February 19th. The company reported ($0.06) earnings per share for the quarter, missing analysts' consensus estimates of $0.06 by ($0.12). The firm had revenue of $270.16 million during the quarter, compared to the consensus estimate of $257.24 million. Klaviyo had a negative net margin of 4.92% and a positive return on equity of 0.89%. Research analysts forecast that Klaviyo, Inc. will post 0.04 earnings per share for the current year.
Klaviyo Profile
(
Free Report)
Klaviyo, Inc, a technology company, provides a software-as-a-service platform in the United States, other Americas, the Asia-Pacific, Europe, the Middle East, and Africa. The company offers Klaviyo, a cloud-native platform for data store, segmentation engine, campaigns and flows, and messaging infrastructure.
See Also

Before you consider Klaviyo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Klaviyo wasn't on the list.
While Klaviyo currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report